End-of-life care of persons with dementia

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 57, Issue 10, 2002, Pages

  Michel, Jean Pierre ^a   Pautex, Sophie ^a   Zekry, Dina ^a   Zulian, Gabriel ^a   Gold, Gilbert ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ALZHEIMER DISEASE; AUTOPSY; CAREGIVER; COHORT ANALYSIS; DEATH; DEMENTIA; FAMILY; HUMAN; LEWY BODY; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; PATIENT ATTITUDE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; TERMINAL CARE;

EID: 0036785282     PISSN: 10795006     EISSN: None     Source Type: Journal    
DOI: 10.1093/gerona/57.10.M640     Document Type: Review

References (62)

1. Souêtre EJ, Quing W, Vigoureux I, et al. Economic analysis of Alzheimer's disease in outpatients: impact of symptom severity, In: Giacobini E, Becker R, eds. Alzheimer's Disease: Therapeutic Strategies. Boston, Mass: Birkhauser; 1994:470-478.
2. Murray CJ, Lorez AD. The Global Burden of Disease. Cambridge, Mass: Harvard University Press; 1997.
3. Katchaturian ZS, Radebaugh TS. AD: Where are we now? Where are we going? Alzheimer Dis Assoc Disord. 1998;12(suppl 3):S24-S28.
4. Ritchie K, Kildea D. Is senile dementia "age related" or "aging related"? Evidence from a meta-analysis of dementia prevalence in the oldest old. Lancet. 1995;346:931-934.
5. Ostbye T, Hill G, Steenhuis R. Mortality in elderly Canadians with and without dementia: a 5-year follow-up. Neurology. 1999;53:521-526.
6. Orrell M, Butler R, Bebbington P. Social factors and the outcome of dementia. Int J Geriatr Psychiatry. 2000;15:515-520.
7. Schaufele M, Bickel H, Weyerer S. Predictors of mortality among demented elderly in primary care. Int J Geriatr Psychiatry. 1999;14: 946-956.
8. Aguero-Torres H, Fratiglioni L, Guo Z, et al. Mortality from dementia in advanced age: a 5-year follow-up study of incident dementia cases. J Clin Epidemiol. 1999;52:737-743.
9. Welch HG, Walsh JS, Larson EB. The cost of institutional care in Alzheimer's disease: nursing home and hospital use in a prospective cohort. J Am Geriatr Soc. 1992;40:221-224.
10. Severson MA, Smith GL, Tangalos EG, et al. Patterns and predictors of institutionalization in community-based dementia patients. J Am Geriatr Soc. 1994;42:181-185.
11. Wolfson CH, Wolfson DB, Asgharian M, et al. A reevaluation of the duration of survival after the onset of dementia. N Engl J Med. 2001; 344:1111-1116.
12. Baldereschi M, Di Carlo A, Maggi S, et al. Dementia as a major predictor of death among Italian elderly. ILSA Working Group. Italian Longitudinal Study on Aging. Neurology. 1999;52:709-713 and comments 2000;54:1014.
13. Broersma F, Van Den Brink W, Deeg DJH, et al. Survival in a population-based cohort of dementia patients: predictors and causes of mortality. Int J Geriatr Psychiatry. 1999;14:748-753.
14. Walker Z, Allen RL, Shergill S, et al. Three years survival in patients with a clinical diagnosis of dementia with Lewy bodies. Int J Geriatr Psychiatry. 2000;15:267-273.
15. Gracon SI, Knapp MJ, Berghoff WG, et al. Safety of tacrine: clinical trials, treatment IND and postmarketing experience, Alzheimer Dis Assoc Disord. 1998;12:93-101.
16. Knopman D, Schneider L, Davis K, et al. Long-term tacrine (Cognex) treatment: effects on nursing home placement and mortality. Neurology. 1996;47:166-177.
17. Henke CJ, Burchmore MJ. The economic impact of tacrine in the treatment of Alzheimer's disease. Clin Ther. 1997;19:1-6.
18. Ott BR, Lapane KL. Tacrine therapy is associated with reduced mortality in nursing home residents with dementia. J Am Geriatr Soc. 2002;50:35-40.
19. Lopez OL, Becker JT, Wisniewski S, et al. Cholinesterase inhibitor treatment alters the natural history of Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2002;72:310-314.
20. National Institute on Aging, Progress Report on Alzheimer's Disease 1998. Bethesda, MD: National Institutes of Health; 1998.
21. Hewer W, Rossler W, Fatkenheuer B, et al. Mortality of patients with organ-induced psychiatric disorders during inpatient psychiatric treatment. Nervenarzt. 1991;62:170-176.
22. Inagaki T, Yamamoto T, Nokura K, et al. Five year follow-up study on dementia in institutions for the elderly. Nippon Ronen Igakkai Zasshi. 1992;29(10):729-734.
23. Kukull WA. Causes of death associated with Alzheimer's disease: variation by level of cognitive impairment before death. J Am Geriatr Soc. 194;42:723-726.
24. Olichney JM, Hofstetter CR, Galasko D, et al. Death certificate reporting of dementia and mortality in an Alzheimer's disease research center cohort. J Am Geriatr Soc. 1995;43:890-893.
25. Thomas BM, Starr JM, Whalley LJ. Death certification in treated cases of presenile Alzheimer's disease and vascular dementia in Scotland. Age Ageing. 1997;26:401-406.
26. Salib E. Autopsy in psychiatric geriatry. Int J Geriatr Psychiatry. 1998;13:747-748.
27. Karolyi G, Karolyi P. Value of mortality data and necropsy records in monitoring morbidity in a population. J Epidemiol Community Health. 1991;45:238-243.
28. Stewart M, McDowell I, Hill G, et al. Estimating antemortem cognitive status of deceased subjects in a longitudinal study of dementia. Int Psychogeriatr. 2000;13(suppl 1):99-106.
29. Klima MP, Povysil C, Teasdale TA. Causes of death in geriatric patients: a cross-cultural study. J Gerontol Med Sci. 1997;52A:M247-M253.
30. Blumenthal HT. The autopsy in gerontological research: a retrospective. J Gerontol Med Sci. 2002;57A:M433-M437.
31. Burns A, Jacoby R, Luthert P, et al. Cause of death in Alzheimer's disease. Age Ageing. 1990;19:341-344.
32. Kammoun S, Gold G, Herrmann F, et al. Immediate causes of death of demented and non-demented elderly: clinical and pathological comparisons. Acta Neurol Scand Suppl. 2000;176:96-99.
33. Hoyert DL, Rosenberg HM. Mortality from Alzheimer's disease: an update. Nat Vital Stat Rep. 1999;47:1-5.
34. Molsa PK, Marttila RJ, Rinne UK. Survival and cause of death in Alzheimer's disease and multi-infarct dementia. Acta Neurol Scand. 1986; 74:103-107.
35. Chandra V, Bharucha NE, Schoenberg BS. Patterns of mortality from types of dementia in the United States, 1971 and 1973-1978. Neurology. 1986;36:204-208.
36. Hwang JP, Tsai SJ, Yang CH. Mortality in geriatric psychiatric inpatients. Int J Psychiatry Med. 1998;28:327-331.
37. Shuster JL. Palliative care for advanced dementia. Clin Geriatr Med. 2000;16:373-386.
38. Abronheim JC, Morrison RS, Baskin SA, et al. Treatment of the dying in the acute care hospital: advanced dementia and metastatic cancer. Arch Intern Med. 1996;156:2094-2100.
39. Michel JP, Gold G. Behavioural symptoms in Alzheimer's disease: validity of targets and present treatments. Age Ageing. 2001;30:105-106.
40. Finkel SI, Burns A. Behavioural and psychological symptoms of dementia (BPSD): a clinical and research update. Int Psychogeriatr. 2000;12:9-12.
41. Schneider L, Pollock VE, Lyness SA. A meta analysis of controlled trials of neuroleptic treatment in dementia. J Am Geriatr Soc. 1990;38: 553-563.
42. Lane HY, Chang YC, Su MH, et al. Shifting from haloperiodol to risperidone for behavioral disturbances in dementia: safety, response predictors, and mood effects. J Clin Psychopharmacol. 2002;22:4-10.
43. Davidson M, Harvey PD, Vervarcke J, et al. A long-term, multicenter, open-label study of risperidone in elderly patients with psychosis. Int J Geriatr Psychiatry. 2000;15:506-514.
44. Teri L, Logsdon RG, Uomoto J, McCurry SM. Behavioural treatment of depression in dementia patients: a controlled clinical trial. J Gerontol Psychol Sci. 1997;52B:P159-P166.
45. Procter R, Burns A, Stratton-Powell H, et al. Behavioural management in nursing and residential homes: a randomised controlled trial. Lancet. 1999;354:26-29.
46. Gormley N, Lyons D, Howard R. Behavioural management of aggression in dementia: a randomised controlled trial. Age Ageing. 2001; 30(2):141-145.
47. Kovach CR, Weissman DE, Griffie J, et al. Assessment and treatment of discomfort for people with late-stage dementia. J Pain Symptom Manage. 1999;18:412-419.
48. Gonthier R, Vassal P, Diana MC, et al. Séméiologie et évaluation de la douleur chez le dément ou non-communicant. Info Kara. 1998;53: 12-23.
49. Farrell MJ, Katz B, Helme RD. The impact of dementia on the pain experience. Pain. 1996;67:7-15.
50. Weissman DE, Matson S. Pain assessment and management in the long-term care setting. Theoretical Med Bioethics. 1999;20:31-43.
51. Flaherty JH. Who's taking your 5th vital sign? J Gerontol Med Sci. 2001;56A:M397-M399.
52. Volicer L, Hurley AC, Blasi ZV. Scales for evaluation of end of life care in dementia. Alzheimer Dis Assoc Disord. 2001;15:194-200.
53. Finucane TE, Christmas C, Travis K. Tube feeding in patients with advanced dementia: a review of the evidence. JAMA. 1999:282:1365-1370. Comments: JAMA. 1999;282:1380-1381; JAMA. 2000;283: 1563-1564.
54. Finucane TE, Christmas C, Travis K. Tube feeding in patients with advanced dementia: a review of the evidence. JAMA. 1999:282:1365-1370. Comments: JAMA. 1999;282:1380-1381; JAMA. 2000;283: 1563-1564.
55. Finucane TE, Christmas C, Travis K. Tube feeding in patients with advanced dementia: a review of the evidence. JAMA. 1999:282:1365-1370. Comments: JAMA. 1999;282:1380-1381; JAMA. 2000;283: 1563-1564.
56. Reynish W, Andrieu S, Nourhashemi F, Vellas B. Nutritional factors and Alzheimer's disease. J Gerontol Med Sci. 2001;56A:M675-M680.
57. Michel JP, Loew F, Brennenstuhl P, et al. Ethique de l'antibiothérapie en médecine de l'âge avancé. Schweiz Med Wosch. 1994;124:2220-2225.
58. Van Nes MC, Huber PH, Zekry D, et al. Considérations sur l'utilisation des antibiotiques chez les malades très âgés. Gériatr Pratique. 1998;4:39-42.
59. Benbow SM. Dementia, grief and dying. Palliat Med. 1990;4:87-92.
60. Hurley AC, Bottino R, Volicer L. Nursing role in advance proxy planning for Alzheimer patients. Caring. 1994;13:72-76.
61. Franken E, Thomas J, Verset C. La mort du vieillard dément. Thanatologie. 1997;31:143-146.
62. Dell'Accio E. Le vécu de deuil des familles ayant accompagné un parent âgé dément. Jalmalv. 2000;60:35-39.